Sopharma Trading AD Statistics

Total Valuation

Sopharma Trading AD has a market cap or net worth of BGN 197.09 million. The enterprise value is 456.25 million.

Market Cap	197.09M
Enterprise Value	456.25M

Important Dates

The last earnings date was Wednesday, October 30, 2024.

Earnings Date	Oct 30, 2024
Ex-Dividend Date	n/a

Share Statistics

Sopharma Trading AD has 34.28 million shares outstanding. The number of shares has increased by 0.65% in one year.

Current Share Class	n/a
Shares Outstanding	34.28M
Shares Change (YoY)	+0.65%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.26%
Float	n/a

Valuation Ratios

The trailing PE ratio is 5.69.

PE Ratio	5.69
Forward PE	n/a
PS Ratio	0.11
PB Ratio	1.34
P/TBV Ratio	n/a
P/FCF Ratio	6.27
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.37, with an EV/FCF ratio of 14.51.

EV / Earnings	13.14
EV / Sales	0.26
EV / EBITDA	5.37
EV / EBIT	9.28
EV / FCF	14.51

Financial Position

The company has a current ratio of 1.10, with a Debt / Equity ratio of 1.84.

Current Ratio	1.10
Quick Ratio	0.60
Debt / Equity	1.84
Debt / EBITDA	3.19
Debt / FCF	8.60
Interest Coverage	5.35

Financial Efficiency

Return on equity (ROE) is 26.59% and return on invested capital (ROIC) is 7.76%.

Return on Equity (ROE)	26.59%
Return on Assets (ROA)	4.61%
Return on Capital (ROIC)	7.76%
Revenue Per Employee	638,431
Profits Per Employee	12,521
Employee Count	2,616
Asset Turnover	2.66
Inventory Turnover	6.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.74% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.74%
50-Day Moving Average	5.78
200-Day Moving Average	5.85
Relative Strength Index (RSI)	47.65
Average Volume (20 Days)	941

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sopharma Trading AD had revenue of BGN 1.77 billion and earned 34.72 million in profits. Earnings per share was 1.01.

Revenue	1.77B
Gross Profit	213.69M
Operating Income	49.19M
Pretax Income	38.03M
Net Income	34.72M
EBITDA	68.23M
EBIT	49.19M
Earnings Per Share (EPS)	1.01

Full Income Statement

Balance Sheet

The company has 11.21 million in cash and 270.37 million in debt, giving a net cash position of -259.16 million or -7.56 per share.

Cash & Cash Equivalents	11.21M
Total Debt	270.37M
Net Cash	-259.16M
Net Cash Per Share	-7.56
Equity (Book Value)	147.21M
Book Value Per Share	4.29
Working Capital	50.97M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 44.19 million and capital expenditures -12.74 million, giving a free cash flow of 31.45 million.

Operating Cash Flow	44.19M
Capital Expenditures	-12.74M
Free Cash Flow	31.45M
FCF Per Share	0.92

Full Cash Flow Statement

Margins

Gross margin is 12.07%, with operating and profit margins of 2.78% and 1.96%.

Gross Margin	12.07%
Operating Margin	2.78%
Pretax Margin	2.15%
Profit Margin	1.96%
EBITDA Margin	3.85%
EBIT Margin	2.78%
FCF Margin	1.78%

Dividends & Yields

Sopharma Trading AD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.65%
Shareholder Yield	-0.65%
Earnings Yield	17.56%
FCF Yield	15.96%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sopharma Trading AD has an Altman Z-Score of 3.22.

Altman Z-Score	3.22
Piotroski F-Score	n/a